Showing results (161-170 of 176) with videos related to
Sort By:
Pageof 18
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Potentiation of cytotoxic drug activity in human tumour cell lines, by amine-substituted 2-arylbenzimidazole-4-carboxamide PARP-1 inhibitorsAlex W White, Nicola J Curtin, Brian W Eastman, et al.ACS Chemical Neuroscience|June 14, 2017
Identification and Profiling of a Selective and Brain Penetrant Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) InhibitorsTravis T Wager, Paul Galatsis, Ramalakshmi Y Chandrasekaran, et al.Journal of Medicinal Chemistry|January 10, 2003
Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitorsDonald J Skalitzky, Joseph T Marakovits, Karen A Maegley, et al.Nature|June 3, 2026
Queen cell architecture shapes honey bee queen developmentYu Fang, Beibei Ma, Xiaolu Jin, et al.Experimental Dermatology|June 13, 2017
Identification of PTPN22, ST6GAL1 and JAZF1 as psoriasis risk genes demonstrates shared pathogenesis between psoriasis and diabetesHonglei Wang, Zhenzhen Wang, Parimi Leela Rani, et al.Journal of Medicinal Chemistry|March 9, 2010
Conformational refinement of hydroxamate-based histone deacetylase inhibitors and exploration of 3-piperidin-3-ylindole analogues of dacinostat (LAQ824)Young Shin Cho, Lewis Whitehead, Jianke Li, et al.Journal of Medicinal Chemistry|August 8, 2013
Ligand-protein interactions of selective casein kinase 1δ inhibitorsScot Mente, Eric Arnold, Todd Butler, et al.Antiviral Therapy|February 2, 2012
Pharmacokinetics and antiviral activity of PHX1766, a novel HCV protease inhibitor, using an accelerated Phase I study designDaphne M Hotho, Joep de Bruijne, A Marie O'Farrell, et al.Journal of the National Cancer Institute|January 8, 2004
Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361Christopher R Calabrese, Robert Almassy, Stephanie Barton, et al.Journal of Medicinal Chemistry|October 16, 2004
Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as inhibitors of poly(ADP-ribose) polymeraseJayashree G Tikhe, Stephen E Webber, Zdenek Hostomsky, et al.Pageof 18